On January 4, 2022, Mr. Timothy Jones, the President and member of the Board of Directors (BOD") of RespireRx Pharmaceuticals Inc. (the Company") notified the Company of his intent to resign which he and the Company subsequently agreed would target January 31, 2022 and would include his resignation as a member of the BOD. The BOD intends to appoint Arnold S. Lippa as the Interim President effective upon Mr. Jones' departure.